Mitochondrial DNA disorders are a group of maternally
inherited clinically and genetically heterogeneous multisystemic disorders.
The mitochondrial DNA mutation screen
includes the analysis for
the point mutations
or large DNA deletions in the mitochondrial genome that cause the mitochondrial
syndromes listed below.
Disorders |
|
|
| MELAS (mitochondrial encephalopathy, lactic acidosis, stroke-like
episodes) |
3243A>G, 3271T>C |
tRNALeu(UUR) |
| MERRF (myoclonic epilepsy and ragged red fibers) |
8344A>G, 8356T>C |
tRNAlys |
| NARP (neuropathy, ataxia, retinitis pigmentosa), Leigh syndrome |
8993T>G, 8993T>C |
ATPase-6 |
Cardiomyopathy |
8363G>A |
tRNAlys |
| Leigh, Leigh-like disease, MELAS |
13513G>A, 13514A>G |
ND5 |
| LHON (Leber’s Optic Neuropathy) |
11778G>A, 3460G>A,
14459G>A, 14484T>C |
ND4, ND1,
ND6 |
| Kearns-Sayre syndrome |
large deletions |
tRNAs+mRNA |
| CPEO (chronic progressive external ophthalmoplegia) |
large deletions |
tRNAs+mRNA |
| Pearson marrow/pancreas syndrome |
large deletions |
tRNAs+mRNA |
Maternally inherited diabetes/hearing
loss |
large deletions |
tRNAs+mRNA |
Mitochondrial DNA Deletion
Syndrome |
|
|
Reasons for Referral:
- Multisystemic disorders involving neuromuscular, neurosensory,
central nervous system, cardiac, renal, hepatic, GI, immune, and endocrine
systems
- Family history of mitochondrial disorders
- Matrilineal family members with known mitochondrial
DNA mutations
- Confirmation of mitochondrial disease
Testing Methodology:
Point mutations are detected by a multiplex PCR/ASO method
and quantified by real time ARMS quantitative PCR. Large deletions are
detected by Southern analysis.
Sensitivity:
Heteroplasmic point mutations at as low as
1% can be detected. Single deletions of larger than 500 bp at greater than
10% heteroplasmy can be detected by Southern analysis.
Blood: EDTA (purple-top)
tubes: Adult: 14 cc; Child: 6
cc; Infant: 2-3 cc. Patients with suspected Kearns-Sayre syndrome should submit muscle specimen for analysis.
Tissue: Skeletal muscle (Preferred). 50 mg for muscle DNA analysis, 150mg for muscle ETC analysis, >200mg if additional tests are requested. Heart, brain, liver, kidney or fibroblast cultures also accepted. 50 mg of heart, brain, liver, kidney or fibroblast for DNA analysis. Tissues such as liver and kidney should be snap-frozen at collection, stored at -70, and shipped on 3-5 lbs of dry ice.
Turnaround Time:
3
weeks
83896x20, 83894x2, 83893x18, 83892x2, 83912, 83901, 83897x2, 83891, 83900
Forms:
>> Mitochondrial
Requisition - Mitochondrial Diagnostic Checklist is included
Recommended
Clinical Testing Algorithm for Mitochondrial Disorders
References:
- Wong
LJC, Boles R. (2005) Mitochondrial DNA in clinical laboratory diagnostics.
Review Article, Clinica Chimica Acta 354: 1-20.
- Shanske S, Wong LJC. (2004) Molecular analysis for mitochondrial DNA disorders. Mitochondrion 4:
403-415.
- Liang MH, Wong LJC. (1998) Yield of mtDNA mutation analysis in 2000 patients. Am.
J. Med. Genet. 77: 395-400.
Test Codes:3000
|